The ophthalmic viscoelastic devices market size has grown steadily in recent years. It will grow from $2.72 billion in 2025 to $2.85 billion in 2026 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to increasing prevalence of cataract surgeries, growing aging population, rising adoption of intraocular surgical procedures, expansion of ophthalmology clinics, improved access to eye care services.
The ophthalmic viscoelastic devices market size is expected to see strong growth in the next few years. It will grow to $3.47 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing demand for premium ophthalmic surgical outcomes, rising focus on complication reduction, expansion of advanced ophthalmic surgery centers, growing investments in eye care infrastructure, increasing adoption of innovative viscoelastic materials. Major trends in the forecast period include increasing adoption of advanced viscoelastic formulations, rising demand for dual-property ovds, growing focus on enhanced tissue protection, expansion of minimally invasive ophthalmic surgeries, improved shelf stability and biocompatibility profiles.
The rising number of ophthalmic surgeries is expected to drive growth in the ophthalmic viscoelastic devices (OVDs) market. Ophthalmic surgeries include procedures such as cataract extraction, corneal transplants, and retinal detachment repair. OVDs are essential in these surgeries, as their viscous and elastic properties help maintain space within the eye, protect delicate structures, facilitate surgical maneuvers, and provide clear visualization. This contributes to better surgical outcomes and reduces complications like tissue trauma and intraoperative issues. For example, in May 2023, the National Health Service England, a UK-based publicly funded healthcare system, reported that cataract surgery accounts for 6% of all surgeries, with over 450,000 procedures performed annually. Projections indicate a 25% increase by 2027 and a 50% rise by 2035 in cataract surgeries, highlighting the growing demand for OVDs.
Major companies in the ophthalmic viscoelastic devices market are focusing on technological innovations, such as line implant-free system solutions, to improve surgical precision and patient outcomes. Advanced line implant-free systems provide non-intrusive solutions that enhance surgical procedures without requiring implants. For example, in April 2023, Bausch + Lomb Corporation, a US-based eye health company, launched the StableVisc cohesive OVD and the TotalVisc Viscoelastic System. StableVisc maintains space in the anterior chamber, facilitating lens extraction and replacement, while the TotalVisc System combines StableVisc and ClearVisc, a dispersive OVD, to protect ocular tissue during surgery. Both products contain sodium hyaluronate and sorbitol, which laboratory studies show offer improved free radical scavenging, providing dual-action mechanical and chemical protection during ophthalmic procedures.
In January 2024, the Netherlands-based pharmaceutical company Nordic Group B.V. acquired Visant Medical, Inc. for an undisclosed sum. This acquisition allows Nordic Group B.V. to enhance its portfolio in the global ophthalmology market and expand its commercialization and development of specialized products across therapeutic areas within ophthalmology. Visant Medical, Inc., a U.S.-based company, focuses on the development of innovative medical devices for ophthalmic applications.
Major companies operating in the ophthalmic viscoelastic devices market are Altacor Ltd., Bausch Health Companies Inc., Bohus Biotech AB, Carl Zeiss Meditec AG, Haohai Biological Technology Co. Ltd., Johnson & Johnson Pvt. Ltd., Novartis International AG, Rumex International Corporation, Rayner Intraocular Lenses Limited, Aurolab, Alcon Inc., Beaver-Visitec International, Neu Micromed International Pvt. Ltd., Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Croma Pharma GmbH, Medicontur Medical Engineering Ltd., Rhein Medical Inc., MicroSurgical Technology, FCI Ophthalmics Inc., Hanita Lenses Ltd., HOYA Medical Singapore Pte. Ltd.
North America was the largest region in the ophthalmic viscoelastic devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global ophthalmic viscoelastic devices market report during the forecast period. The regions covered in the ophthalmic viscoelastic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic viscoelastic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ophthalmic viscoelastic devices market by increasing costs of imported pharmaceutical-grade polymers, sterilization materials, medical packaging, and precision manufacturing equipment. Hospitals and ophthalmology clinics in North America and Europe are most affected due to dependence on imported raw materials and specialized production inputs, while Asia-Pacific faces pricing pressure on exports. These tariffs are increasing production costs and influencing pricing strategies for surgical consumables. However, they are also encouraging localized manufacturing, regional sourcing of biomaterials, and long-term investments in domestic ophthalmic device production capabilities.
The ophthalmic viscoelastic devices market research report is one of a series of new reports that provides ophthalmic viscoelastic devices market statistics, including ophthalmic viscoelastic devices industry global market size, regional shares, competitors with a ophthalmic viscoelastic devices market share, detailed ophthalmic viscoelastic devices market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic viscoelastic devices industry. This ophthalmic viscoelastic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ophthalmic viscoelastic devices (OVDs) are gel-such as substances utilized in specific eye surgeries to establish and maintain intraocular space, safeguard delicate eye structures, and aid in surgical maneuvers. These substances typically possess a clear, viscous, and elastic nature, mimicking the properties of natural fluids found within the eye.
The primary categories of OVDs are cohesive ophthalmic viscoelastics and dispersive ophthalmic viscoelastics. Cohesive ophthalmic viscoelastics are highly viscous and cohesive, maintaining their form as a single mass rather than dispersing within the eye. They are predominantly employed in cataract surgery but also find application in procedures such as glaucoma surgery, corneal transplant, and vitreoretinal surgery. These substances are utilized by various entities, including hospitals, ophthalmology clinics, and similar medical facilities.
The ophthalmic viscoelastic devices market consists of sales of cohesive OVDs, dispersive OVDs, and combined OVDs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ophthalmic viscoelastic devices market size is expected to see strong growth in the next few years. It will grow to $3.47 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing demand for premium ophthalmic surgical outcomes, rising focus on complication reduction, expansion of advanced ophthalmic surgery centers, growing investments in eye care infrastructure, increasing adoption of innovative viscoelastic materials. Major trends in the forecast period include increasing adoption of advanced viscoelastic formulations, rising demand for dual-property ovds, growing focus on enhanced tissue protection, expansion of minimally invasive ophthalmic surgeries, improved shelf stability and biocompatibility profiles.
The rising number of ophthalmic surgeries is expected to drive growth in the ophthalmic viscoelastic devices (OVDs) market. Ophthalmic surgeries include procedures such as cataract extraction, corneal transplants, and retinal detachment repair. OVDs are essential in these surgeries, as their viscous and elastic properties help maintain space within the eye, protect delicate structures, facilitate surgical maneuvers, and provide clear visualization. This contributes to better surgical outcomes and reduces complications like tissue trauma and intraoperative issues. For example, in May 2023, the National Health Service England, a UK-based publicly funded healthcare system, reported that cataract surgery accounts for 6% of all surgeries, with over 450,000 procedures performed annually. Projections indicate a 25% increase by 2027 and a 50% rise by 2035 in cataract surgeries, highlighting the growing demand for OVDs.
Major companies in the ophthalmic viscoelastic devices market are focusing on technological innovations, such as line implant-free system solutions, to improve surgical precision and patient outcomes. Advanced line implant-free systems provide non-intrusive solutions that enhance surgical procedures without requiring implants. For example, in April 2023, Bausch + Lomb Corporation, a US-based eye health company, launched the StableVisc cohesive OVD and the TotalVisc Viscoelastic System. StableVisc maintains space in the anterior chamber, facilitating lens extraction and replacement, while the TotalVisc System combines StableVisc and ClearVisc, a dispersive OVD, to protect ocular tissue during surgery. Both products contain sodium hyaluronate and sorbitol, which laboratory studies show offer improved free radical scavenging, providing dual-action mechanical and chemical protection during ophthalmic procedures.
In January 2024, the Netherlands-based pharmaceutical company Nordic Group B.V. acquired Visant Medical, Inc. for an undisclosed sum. This acquisition allows Nordic Group B.V. to enhance its portfolio in the global ophthalmology market and expand its commercialization and development of specialized products across therapeutic areas within ophthalmology. Visant Medical, Inc., a U.S.-based company, focuses on the development of innovative medical devices for ophthalmic applications.
Major companies operating in the ophthalmic viscoelastic devices market are Altacor Ltd., Bausch Health Companies Inc., Bohus Biotech AB, Carl Zeiss Meditec AG, Haohai Biological Technology Co. Ltd., Johnson & Johnson Pvt. Ltd., Novartis International AG, Rumex International Corporation, Rayner Intraocular Lenses Limited, Aurolab, Alcon Inc., Beaver-Visitec International, Neu Micromed International Pvt. Ltd., Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Croma Pharma GmbH, Medicontur Medical Engineering Ltd., Rhein Medical Inc., MicroSurgical Technology, FCI Ophthalmics Inc., Hanita Lenses Ltd., HOYA Medical Singapore Pte. Ltd.
North America was the largest region in the ophthalmic viscoelastic devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global ophthalmic viscoelastic devices market report during the forecast period. The regions covered in the ophthalmic viscoelastic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic viscoelastic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ophthalmic viscoelastic devices market by increasing costs of imported pharmaceutical-grade polymers, sterilization materials, medical packaging, and precision manufacturing equipment. Hospitals and ophthalmology clinics in North America and Europe are most affected due to dependence on imported raw materials and specialized production inputs, while Asia-Pacific faces pricing pressure on exports. These tariffs are increasing production costs and influencing pricing strategies for surgical consumables. However, they are also encouraging localized manufacturing, regional sourcing of biomaterials, and long-term investments in domestic ophthalmic device production capabilities.
The ophthalmic viscoelastic devices market research report is one of a series of new reports that provides ophthalmic viscoelastic devices market statistics, including ophthalmic viscoelastic devices industry global market size, regional shares, competitors with a ophthalmic viscoelastic devices market share, detailed ophthalmic viscoelastic devices market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic viscoelastic devices industry. This ophthalmic viscoelastic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ophthalmic viscoelastic devices (OVDs) are gel-such as substances utilized in specific eye surgeries to establish and maintain intraocular space, safeguard delicate eye structures, and aid in surgical maneuvers. These substances typically possess a clear, viscous, and elastic nature, mimicking the properties of natural fluids found within the eye.
The primary categories of OVDs are cohesive ophthalmic viscoelastics and dispersive ophthalmic viscoelastics. Cohesive ophthalmic viscoelastics are highly viscous and cohesive, maintaining their form as a single mass rather than dispersing within the eye. They are predominantly employed in cataract surgery but also find application in procedures such as glaucoma surgery, corneal transplant, and vitreoretinal surgery. These substances are utilized by various entities, including hospitals, ophthalmology clinics, and similar medical facilities.
The ophthalmic viscoelastic devices market consists of sales of cohesive OVDs, dispersive OVDs, and combined OVDs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ophthalmic Viscoelastic Devices Market Characteristics
3. Ophthalmic Viscoelastic Devices Market Supply Chain Analysis
4. Global Ophthalmic Viscoelastic Devices Market Trends and Strategies
5. Ophthalmic Viscoelastic Devices Market Analysis of End Use Industries
7. Global Ophthalmic Viscoelastic Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ophthalmic Viscoelastic Devices Total Addressable Market (TAM) Analysis for the Market
9. Ophthalmic Viscoelastic Devices Market Segmentation
10. Ophthalmic Viscoelastic Devices Market Regional and Country Analysis
11. Asia-Pacific Ophthalmic Viscoelastic Devices Market
12. China Ophthalmic Viscoelastic Devices Market
13. India Ophthalmic Viscoelastic Devices Market
14. Japan Ophthalmic Viscoelastic Devices Market
15. Australia Ophthalmic Viscoelastic Devices Market
16. Indonesia Ophthalmic Viscoelastic Devices Market
17. South Korea Ophthalmic Viscoelastic Devices Market
18. Taiwan Ophthalmic Viscoelastic Devices Market
19. South East Asia Ophthalmic Viscoelastic Devices Market
20. Western Europe Ophthalmic Viscoelastic Devices Market
21. UK Ophthalmic Viscoelastic Devices Market
22. Germany Ophthalmic Viscoelastic Devices Market
23. France Ophthalmic Viscoelastic Devices Market
24. Italy Ophthalmic Viscoelastic Devices Market
25. Spain Ophthalmic Viscoelastic Devices Market
26. Eastern Europe Ophthalmic Viscoelastic Devices Market
27. Russia Ophthalmic Viscoelastic Devices Market
28. North America Ophthalmic Viscoelastic Devices Market
29. USA Ophthalmic Viscoelastic Devices Market
30. Canada Ophthalmic Viscoelastic Devices Market
31. South America Ophthalmic Viscoelastic Devices Market
32. Brazil Ophthalmic Viscoelastic Devices Market
33. Middle East Ophthalmic Viscoelastic Devices Market
34. Africa Ophthalmic Viscoelastic Devices Market
36. Ophthalmic Viscoelastic Devices Market Competitive Landscape and Company Profiles
37. Ophthalmic Viscoelastic Devices Market Other Major and Innovative Companies
40. Ophthalmic Viscoelastic Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Ophthalmic Viscoelastic Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ophthalmic viscoelastic devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ophthalmic viscoelastic devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic viscoelastic devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Cohesive Ophthalmic Viscoelastic; Dispersive Ophthalmic Viscoelastic2) By Application: Cataract Surgery; Glaucoma Surgery; Corneal Transplant; Vitreoretinal Surgery
3) By End User: Hospital; Ophthalmology Clinics; Other End-Users
Subsegments:
1) By Cohesive Ophthalmic Viscoelastic: Sodium Hyaluronate; Hyaluronic Acid2) By Dispersive Ophthalmic Viscoelastic: Sodium Chondroitin Sulfate; Dispersive Hydrogel
Companies Mentioned: Altacor Ltd.; Bausch Health Companies Inc.; Bohus Biotech AB; Carl Zeiss Meditec AG; Haohai Biological Technology Co. Ltd.; Johnson & Johnson Pvt. Ltd.; Novartis International AG; Rumex International Corporation; Rayner Intraocular Lenses Limited; Aurolab; Alcon Inc.; Beaver-Visitec International; Neu Micromed International Pvt. Ltd.; Abbott Medical Optics; Maxigen Biotech Inc.; Amring Pharmaceuticals Inc.; Croma Pharma GmbH; Medicontur Medical Engineering Ltd.; Rhein Medical Inc.; MicroSurgical Technology; FCI Ophthalmics Inc.; Hanita Lenses Ltd.; HOYA Medical Singapore Pte. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ophthalmic Viscoelastic Devices market report include:- Altacor Ltd.
- Bausch Health Companies Inc.
- Bohus Biotech AB
- Carl Zeiss Meditec AG
- Haohai Biological Technology Co. Ltd.
- Johnson & Johnson Pvt. Ltd.
- Novartis International AG
- Rumex International Corporation
- Rayner Intraocular Lenses Limited
- Aurolab
- Alcon Inc.
- Beaver-Visitec International
- Neu Micromed International Pvt. Ltd.
- Abbott Medical Optics
- Maxigen Biotech Inc.
- Amring Pharmaceuticals Inc.
- Croma Pharma GmbH
- Medicontur Medical Engineering Ltd.
- Rhein Medical Inc.
- MicroSurgical Technology
- FCI Ophthalmics Inc.
- Hanita Lenses Ltd.
- HOYA Medical Singapore Pte. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.85 Billion |
| Forecasted Market Value ( USD | $ 3.47 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
